The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
The COVID-19 pandemic: a global health crisis
Open accessAbstract
The novel coronavirus SARS-CoV-2 was identified as the causative agent for a series of atypical respiratory diseases in the Hubei Province of Wuhan, China in December of 2019. The disease SARS-CoV-2, termed COVID-19, was officially declared a pandemic by the World Health Organization on March 11, 2020. SARS-CoV-2 contains a single-stranded, positive-sense RNA genome surrounded by an extracellular membrane containing a series of spike glycoproteins resembling a crown. COVID-19 infection results in diverse symptoms and morbidity depending on individual genetics, ethnicity, age, and geographic location. In severe cases, COVID-19 pathophysiology includes destruction of lung epithelial cells, thrombosis, hypercoagulation, and vascular leak leading to sepsis. These events lead to acute respiratory distress syndrome (ARDS) and subsequent pulmonary fibrosis in patients. COVID-19 risk factors include cardiovascular disease, hypertension, and diabetes, which are highly prevalent in the United States. This population has upregulation of the angiotensin converting enzyme-2 (ACE2) receptor, which is exploited by COVID-19 as the route of entry and infection. Viral envelope proteins bind to and degrade ACE2 receptors, thus preventing normal ACE2 function. COVID-19 infection causes imbalances in ACE2 and induces an inflammatory immune response, known as a cytokine storm, both of which amplify comorbidities within the host. Herein, we discuss the genetics, pathogenesis, and possible therapeutics of COVID-19 infection along with secondary complications associated with disease progression, including ARDS and pulmonary fibrosis. Understanding the mechanisms of COVID-19 infection will allow the development of vaccines or other novel therapeutic approaches to prevent transmission or reduce the severity of infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
COVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0754-0 · Cited by 2,287
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.4783 · Cited by 2,277
COVID-19 pathophysiology: A review
Yuki, K., Fujiogi, M., & Koutsogiannaki, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108427 · Cited by 2,206
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., Bi, Z., & Zhao, Y. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01626-9 · Cited by 2,057
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., Hu, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004168117 · Cited by 1,960
Signaling Mechanisms Regulating Endothelial Permeability
Mehta, D., & Malik, A. B. (2006) · Physiological Reviews · doi:10.1152/physrev.00012.2005 · Cited by 1,720
Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
The COVID-19 Cytokine Storm; What We Know So Far
Ragab, D., Salah Eldin, H., Taeimah, M., Khattab, R., & Salem, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01446 · Cited by 1,622
On the origin and continuing evolution of SARS-CoV-2
Tang, X., Wu, C., Li, X., Song, Y., Yao, X., Wu, X., Duan, Y., Zhang, H., Wang, Y., Qian, Z., et al. (2020) · National Science Review · doi:10.1093/nsr/nwaa036 · Cited by 1,616
Virology, Epidemiology, Pathogenesis, and Control of COVID-19
Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W., & Duan, G. (2020) · Viruses · doi:10.3390/v12040372 · Cited by 1,603
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
Coagulation abnormalities and thrombosis in patients with COVID-19
Levi, M., Thachil, J., Iba, T., & Levy, J. H. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30145-9 · Cited by 1,544
Guzik, T. J., Mohiddin, S. A., Dimarco, A., Patel, V., Savvatis, K., Marelli-Berg, F. M., Madhur, M. S., Tomaszewski, M., Maffia, P., D’Acquisto, F., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa106 · Cited by 1,440
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Matsuyama, S., Nao, N., Shirato, K., Kawase, M., Saito, S., Takayama, I., Nagata, N., Sekizuka, T., Katoh, H., Kato, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002589117 · Cited by 1,411
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256
Tian, X., Li, C., Huang, A., Xia, S., Lu, S., Shi, Z., Lu, L., Jiang, S., Yang, Z., Wu, Y., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1729069 · Cited by 1,252
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.037 · Cited by 1,237
The Molecular Biology of Coronaviruses
Lai, M. M. C., & Cavanagh, D. (1997) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60286-9 · Cited by 1,143
SARS-CoV-2 Vaccines: Status Report
Amanat, F., & Krammer, F. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.007 · Cited by 1,120
Phylogenetic network analysis of SARS-CoV-2 genomes
Forster, P., Forster, L., Renfrew, C., & Forster, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004999117 · Cited by 1,020
Cytoskeletal regulation of pulmonary vascular permeability
Dudek, S. M., & Garcia, J. G. N. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.4.1487 · Cited by 985
COVID ‐19 and Older Adults: What We Know
Shahid, Z., Kalayanamitra, R., McClafferty, B., Kepko, D., Ramgobin, D., Patel, R., Aggarwal, C. S., Vunnam, R., Sahu, N., Bhatt, D., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16472 · Cited by 909
Cao, Y., Li, L., Feng, Z., Wan, S., Huang, P., Sun, X., Wen, F., Huang, X., Ning, G., & Wang, W. (2020) · Cell Discovery · doi:10.1038/s41421-020-0147-1 · Cited by 865
Care for Critically Ill Patients With COVID-19
Murthy, S., Gomersall, C. D., & Fowler, R. A. (2020) · JAMA · doi:10.1001/jama.2020.3633 · Cited by 779
Badawi, A., & Ryoo, S. G. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.06.015 · Cited by 703
Matthay, M. A., & Zimmerman, G. A. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.f305 · Cited by 642
Wu, J., Wu, X., Zeng, W., Guo, D., Fang, Z., Chen, L., Huang, H., & Li, C. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000670 · Cited by 629
History and Recent Advances in Coronavirus Discovery
Kahn, J. S., & McIntosh, K. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000188166.17324.60 · Cited by 619
Artificial intelligence and machine learning to fight COVID-19
Alimadadi, A., Aryal, S., Manandhar, I., Munroe, P. B., Joe, B., & Cheng, X. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00029.2020 · Cited by 608
Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
Lu, G., Wang, Q., & Gao, G. F. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.06.003 · Cited by 607
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2
Nguyen, A., David, J. K., Maden, S. K., Wood, M. A., Weeder, B. R., Nellore, A., & Thompson, R. F. (2020) · Journal of Virology · doi:10.1128/jvi.00510-20 · Cited by 561
Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction
Huang, X., Yang, N., Fiore, V. F., Barker, T. H., Sun, Y., Morris, S. W., Ding, Q., Thannickal, V. J., & Zhou, Y. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0050oc · Cited by 530
Pathogenesis of Acute Respiratory Distress Syndrome
Huppert, L., Matthay, M., & Ware, L. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1683996 · Cited by 459
Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA
Ferron, F., Subissi, L., Silveira De Morais, A. T., Le, N. T. T., Sevajol, M., Gluais, L., Decroly, E., Vonrhein, C., Bricogne, G., Canard, B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718806115 · Cited by 404
Genomic variance of the 2019‐nCoV coronavirus
Ceraolo, C., & Giorgi, F. M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25700 · Cited by 397
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
Robson, F., Khan, K. S., Le, T. K., Paris, C., Demirbag, S., Barfuss, P., Rocchi, P., & Ng, W.-L. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.07.027 · Cited by 396
Gemmati, D., Bramanti, B., Serino, M. L., Secchiero, P., Zauli, G., & Tisato, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103474 · Cited by 395
The Burden of Cardiovascular Diseases Among US States, 1990-2016
Global Burden of Cardiovascular Diseases Collaboration, Roth, G. A., Johnson, C. O., Abate, K. H., Abd-Allah, F., Ahmed, M., Alam, K., Alam, T., Alvis-Guzman, N., Ansari, H., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.0385 · Cited by 389
Association of HLA class I with severe acute respiratory syndrome coronavirus infection
Lin, M., Tseng, H.-K., Trejaut, J. A., Lee, H.-L., Loo, J.-H., Chu, C.-C., Chen, P.-J., Su, Y.-W., Lim, K. H., Tsai, Z.-U., et al. (2003) · BMC Medical Genetics · doi:10.1186/1471-2350-4-9 · Cited by 326
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
Uddin, M., Mustafa, F., Rizvi, T. A., Loney, T., Al Suwaidi, H., Al-Marzouqi, A. H. H., Kamal Eldin, A., Alsabeeha, N., Adrian, T. E., Stefanini, C., et al. (2020) · Viruses · doi:10.3390/v12050526 · Cited by 319
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
Suryamohan, K., Diwanji, D., Stawiski, E. W., Gupta, R., Miersch, S., Liu, J., Chen, C., Jiang, Y.-P., Fellouse, F. A., Sathirapongsasuti, J. F., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02030-3 · Cited by 299
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
Shang, W., Yang, Y., Rao, Y., & Rao, X. (2020) · npj Vaccines · doi:10.1038/s41541-020-0170-0 · Cited by 275
Tan, W., & Aboulhosn, J. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.03.063 · Cited by 268
Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases
Woodring, P. J., Hunter, T., & Wang, J. Y. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00622 · Cited by 227
Immune-epidemiological parameters of the novel coronavirus – a perspective
Saghazadeh, A., & Rezaei, N. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1750954 · Cited by 223
A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
Casanova, J.-L., Su, H. C., Abel, L., Aiuti, A., Almuhsen, S., Arias, A. A., Bastard, P., Biggs, C., Bogunovic, D., Boisson, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.016 · Cited by 217
The Capable ABL: What Is Its Biological Function?
Wang, J. Y. J. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01454-13 · Cited by 193
Barkauskas, C. E., & Noble, P. W. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00321.2013 · Cited by 167
Meng, Y., Li, T., Zhou, G.-S., Chen, Y., Yu, C., Pang, M.-X., Li, W., Li, Y., Zhang, W., & Li, X. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5818 · Cited by 157
Increased Plasma Heparanase Activity in COVID-19 Patients
Buijsers, B., Yanginlar, C., de Nooijer, A., Grondman, I., Maciej-Hulme, M. L., Jonkman, I., Janssen, N. A. F., Rother, N., de Graaf, M. J. J., Pickkers, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575047 · Cited by 146
Matrix stiffness regulates migration of human lung fibroblasts
Asano, S., Ito, S., Takahashi, K., Furuya, K., Kondo, M., Sokabe, M., & Hasegawa, Y. (2017) · Physiological Reports · doi:10.14814/phy2.13281 · Cited by 143
Multifunctional Abl kinases in health and disease
Khatri, A., Wang, J., & Pendergast, A. M. (2016) · Journal of Cell Science · doi:10.1242/jcs.175521 · Cited by 137
Recombinant Canine Coronaviruses in Dogs, Europe
Decaro, N., Mari, V., Elia, G., et al. (2009) · Emerging infectious diseases · doi:10.3201/eid1601.090726 · Cited by 129
Hodgson, J. (2020) · Nature Biotechnology · doi:10.1038/d41587-020-00005-z · Cited by 128
Abl tyrosine kinases regulate cell–cell adhesion through Rho GTPases
Zandy, N. L., Playford, M. P., & Pendergast, A. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703077104 · Cited by 125
Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease
Golonka, R. M., Saha, P., Yeoh, B. S., Chattopadhyay, S., Gewirtz, A. T., Joe, B., & Vijay–Kumar, M. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00033.2020 · Cited by 104
Tu, X., Chong, W. P., Zhai, Y., Zhang, H., Zhang, F., Wang, S., Liu, W. Y., Wei, M., Siu, N. H. O., Yang, H., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.03.006 · Cited by 103
Clinical Features of Cytokine Storm Syndrome
Shimizu, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-22094-5_3 · Cited by 101
Rizzo, A. N., Aman, J., Amerongen, G. P. V. N., & Dudek, S. M. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305085 · Cited by 96
Pathophysiology and biomarkers of acute respiratory distress syndrome
Fujishima, S. (2014) · Journal of Intensive Care · doi:10.1186/2052-0492-2-32 · Cited by 95
Lippi, G., Lavie, C. J., Henry, B. M., & Sanchis‐Gomar, F. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0727 · Cited by 71
Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury
Letsiou, E., Rizzo, A. N., Sammani, S., Naureckas, P., Jacobson, J. R., Garcia, J. G. N., & Dudek, S. M. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00323.2014 · Cited by 66
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl
Wang, L., Chiang, E. T., Simmons, J. T., Garcia, J. G. N., & Dudek, S. M. (2010) · European Respiratory Journal · doi:10.1183/09031936.00047810 · Cited by 59
TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells
Zmora, P., Moldenhauer, A.-S., Hofmann-Winkler, H., & Pöhlmann, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138380 · Cited by 56
Mohammadpour, S., Esfahani, A. T., Halaji, M., Lak, M., & Ranjbar, R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29868 · Cited by 55
Karki, P., & Birukova, A. A. (2018) · Pulmonary Circulation · doi:10.1177/2045894018773044 · Cited by 43
Tang, F., Liu, W., Zhang, F., Xin, Z.-T., Wei, M.-T., Zhang, P. H., Yang, H., Ly, H., & Cao, W.-C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002183 · Cited by 41
Coronavirus disease 2019 and the cardiovascular system: Impacts and implications
Gupta, M. D., Girish, M. P., Yadav, G., Shankar, A., & Yadav, R. K. (2020) · Indian Heart Journal · doi:10.1016/j.ihj.2020.03.006 · Cited by 23
Hyperoxia increases the elastic modulus of alveolar epithelial cells through Rho kinase
Wilhelm, K., Roan, E., Ghosh, M. C., Parthasarathi, K., & Waters, C. M. (2013) · FEBS Journal · doi:10.1111/febs.12661 · Cited by 20
Cited by
COVID-19 and autoimmune diseases
Liu, Y., Sawalha, A. H., & Lu, Q. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000776 · Cited by 476
Wong, T. L., & Weitzer, D. J. (2021) · Medicina · doi:10.3390/medicina57050418 · Cited by 446
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
Drożdżal, S., Rosik, J., Lechowicz, K., Machaj, F., Szostak, B., Przybyciński, J., Lorzadeh, S., Kotfis, K., Ghavami, S., & Łos, M. J. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100794 · Cited by 286
Klein, S., Fegert, J. M., Geprägs, A., Brähler, E., & Clemens, V. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.844057 · Cited by 17
Metadata
- Authors
- Pollard, C. A., Morran, M. P., & Nestor-Kalinoski, A. L.
- Venue
- Physiological Genomics
- Publisher
- American Physiological Society
- Published
- 2020-11-01
- Volume
- 52
- Issue
- 11
- Pages
- 549-557
- ISSN
- 1094-8341 (ISSN-L)
- 1531-2267
- OpenAlex
- W3091759688
- Cited by
- 514
- References
- 81
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.